Cupps Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Cupps Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$805K	Sell	17,459 -21,411	-55%	-$1.21M	0.35%	102
2016 Q2	$1.98M	Buy	38,870 +25,690	+195%	+$1.28M	0.51%	79
2016 Q1	$557K	Sell	13,180 -29,850	-69%	-$1.52M	0.11%	146
2015 Q4	$3.38M	Buy	+43,030	New	+$2.49M	0.47%	78
2015 Q2	–	Sell	-117,541	Closed	-$5.47M	–	223
2015 Q1	$5.47M	Sell	117,541 -9,240	-7%	-$480K	0.49%	77
2014 Q4	$5.69M	Buy	126,781 +99,126	+358%	+$4.16M	0.51%	68
2014 Q3	$1.08M	Sell	27,655 -20,700	-43%	-$812K	0.1%	139
2014 Q2	$2.04M	Buy	+48,355	New	+$1.77M	0.17%	125

Other funds holding ISEE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

JCG

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TBC

Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cupps Capital Management's ISEE Position: Q3 2016 in Review

Cupps Capital Management reduced its IVERIC bio, Inc. Common Stock (ISEE) stake by 55% in Q3 2016, selling an estimated $1.21M and leaving 17,459 shares worth $805K. The position accounts for 0.35% of the portfolio, ranked #102.

Cupps Capital Management first reported a position in ISEE in Q2 2014 and has held it in 8 quarters since. The position peaked at $5.69M in Q4 2014. 192 funds tracked by Wall St. Rank hold ISEE as of Q3 2016.

Cupps Capital Management held 17,459 shares of IVERIC bio, Inc. Common Stock worth $805K as of Q3 2016.
Cupps Capital Management sold 21,411 IVERIC bio, Inc. Common Stock shares in Q3 2016, an estimated $1.21M.
IVERIC bio, Inc. Common Stock made up 0.35% of Cupps Capital Management's portfolio in Q3 2016, its #102 holding.
Cupps Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and has held it in 8 quarters since.
Cupps Capital Management's IVERIC bio, Inc. Common Stock position peaked at $5.69M in Q4 2014.
192 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.